Microglial BDNF modulates arketamine’s antidepressant-like effects through cortico-accumbal pathways
Science Advances · 2025
DOI: 10.1126/sciadv.adv5986 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Lujuan He und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, School of Medicine, Jinan University, Guangzhou, 510632, China. Hauptthemen laut MEDLINE: Brain-Derived Neurotrophic Factor, Ketamine, Antidepressive Agents, Microglia. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Arketamine, the ( R )-enantiomer of ( R,S )-ketamine, shows even greater rapid and sustained antidepressant-like effects in rodent models compared to esketamine, yet the underlying mechanisms remain unclear. In this study, we used the chronic social defeat stress (CSDS) model to investigate how arketamine exerts its antidepressant-like effects. We found that activating cAMP response element–binding protein (CREB) at S133 and methyl-CpG–binding protein 2 (MeCP2) at S421 drives the transcription of brain-derived neurotrophic factor (BDNF), contributing to arketamine’s antidepressant-like effects. Furthermore, microglia-derived BDNF enhances excitatory synaptic transmission in the infralimbic (IL) region of the medial prefrontal cortex (mPFC), mediating the antidepressant-like effects of arketamine in CSDS-susceptible mice. Last, microglia-derived BDNF can activate mPFC (IL) neurons projecting to the nucleus accumbens (NAc) shell, contributing to arketamine’s antidepressant-like effects. These findings highlight the essential role of microglial BDNF in modulating NAc-projecting mPFC neurons, which contribute to the antidepressant-like effects of arketamine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Physiology, School of Medicine, Jinan University, Guangzhou, 510632, China.
- Institute of Brain Science and Brain-inspired Research, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, China.
- Department of Neurology, Xiangya Hospital, National Clinical Research Center for Geriatric Disorders, and Department of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha, 410008, China.
- Guangzhou Key Laboratory of Formula-pattern Research Center, School of Traditional Chinese Medicine, Jinan University, Guangzhou, 510632, China.
- Department of Anesthesiology and Perioperative Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.
- Chiba University Center for Forensic Mental Health, Chiba, 260-8670, Japan.
ORCID-Profile: Lujuan He, Shilin Luo, Chun Yang, Wei Yao, Kenji Hashimoto, Ji-Chun Zhang
Zitieren
APA
He, L., Wang, X., Luo, S., Jiang, N., Yan, Y., Xie, M., Chen, Y., Yang, C., Yao, W., Hashimoto, K., & Zhang, J. C. (2025). Microglial BDNF modulates arketamine’s antidepressant-like effects through cortico-accumbal pathways. Science Advances. https://doi.org/10.1126/sciadv.adv5986
Vancouver
He L, Wang X, Luo S, Jiang N, Yan Y, Xie M, et al. Microglial BDNF modulates arketamine’s antidepressant-like effects through cortico-accumbal pathways. Science Advances. 2025. doi:10.1126/sciadv.adv5986
BibTeX
@article{He2025,
author = {He, Lujuan and Wang, Xuenan and Luo, Shilin and Jiang, Nan and Yan, Yu and Xie, Min and Chen, Yueyue and Yang, Chun and Yao, Wei and Hashimoto, Kenji and Zhang, Ji-Chun},
title = {Microglial BDNF modulates arketamine’s antidepressant-like effects through cortico-accumbal pathways},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.adv5986}
}
EUVIMED